Skin Cancer Screening

CATCHING IT EARLY

EVERY SIX MONTHS

Every single hour, someone dies of melanoma. That statistic could be reduced dramatically if the cancer is caught earlier. Early skin cancer does not have the ability to spread through the body! Even though the cells multiply, the cancer can’t invade other layers of skin in the early stages. Only over time do genetic changes occur enabling it to spread. This is precisely why early detection is so vital. Early detection is something Dr. Shore has been advocating for a quarter of a century. At his dermatology practice, he has persuaded high risk patients to come in for check-ups every six months. The results?

In over 25 years, not one person in the program has died from skin cancer or even had a close call:

The Skin Check Program – 1992 to Present

OVER

1
skin examinations performed

OVER

1
Skin Cancers Detected

OVER

1
Melanomas detected

But NO DEATHS due to any skin cancers

FOUNDERS' COMMENTARY

Full skin examinations, if performed in a serial manner, ideally every 6 to 12 months, by dermatologists or other medical personnel who have been specifically trained for this procedure, can result in cures of skin cancer in almost all cases. We recommend such examinations for individuals with a history of significant past sun or ultraviolet light exposure (e.g. tanning salons), particularly if there have been severe or blistering sunburns at any time in the past, since this predisposes to melanoma in particular. In addition, we recommend these examinations for individuals with the following additional risk factors.

Fair skin types.

Red or blond hair.

Numerous moles.

Past history of any skin cancer.

Family history of melanoma.

Although not widely known by the public at this time, light skinned men over 50 are particularly at risk for both developing and dying of melanoma. We highly recommend that such individuals, particularly those with a history of multiple and/or severe sunburns, participate in serial screening programs. Doing so could be life-saving.

Get the latest updates on our research.

Delivering Cures for Cancer
c/o PSSF Foundation
4701 Randolph Rd.
Suite 207
Rockville MD 20852
*All donations are tax deductible.

OR DONATE ONLINE

support us and change
the future of cancer.

Drs. Ronald Shore and Joseph Fox, who founded Delivering Cures for Cancer and The Paula Shore/Sari Fox Foundation, receive no salary, income or other compensation from the Foundation. Their donations have covered the majority of the start up costs including website, legal, accounting, administrative, and promotions expenses. Dr. Shore, whose skin cancer screening program is described on this website, has helped to educate fellow dermatologists and other medical personnel on how to perform highly effective skin cancer screening through international lectures and publications, largely at personal expense. Honoraria for his presentations, if provided, have been returned to the institution (e.g. University of Pennsylvania), or given to charity (e.g. The Society for Dermatologic Physician Assistants).  He receives no other compensation from industry, academic institutions or other entities. Dr. Shore has volunteered his time and knowledge on screening to 20/20 GeneSystems, Inc., the developer of the PAULAs Test, a new blood test for early detection of lung cancer.  He has also served on its Medical Advisory Board. He has received no remuneration for these forms of assistance. Dr. Shore and Dr. Fox were each approached by 20/20 GeneSystems, Inc. to purchase shares to help the company continue its research, and both agreed to do so. Their investments in the company, in each case, represent well under 1% of total investments. Neither physician holds any controlling or voting position in the company, nor draws any salary or other compensation. Dr. Shore and Dr. Fox, who for several years have spoken to various individualsorganizations and government personnel to try to advance Dr. Esther Chang’s research, were each approached by SynerGeneTherapeutics, Inc., the financial entity helping to fund her research, to purchase shares to help her continue her clinical trials. Both agreed to do so. Their investments in the company, in each case, represent well under 1% of total investments.  Neither physician holds any controlling or voting position in the company, nor draws any salary or other compensation. Other members of the Shore and Fox families have assisted the development of the Foundation and its website through donations, administrative assistance, and technical assistance preparing the videos.  No members of either family have drawn salaries nor received other compensation. Dr. Esther Chang was asked by the Founders to act as an advisor and to provide technical assistance, particularly regarding development of the videos on the website that explain her technology, and she agreed to do so.  She holds no controlling or voting position on Delivering Cures for Cancer or the Paula Shore/Sari Fox Foundation, nor draws any salary or other compensation. Delivering Cures for Cancer (DC4C) was formerly known as, and remains the organization’s legal 501(c)(3) entity under the name The Paula Shore/Sari Fox Foundation (PSSF). Dr. Ronald Shore, Dr. Joseph Fox – December 31, 2014